Document is current
Any future updates will be listed below
-
Authors
Trudzinski, Franziska C. http://orcid.org/0000-0002-0980-7586
Jörres, Rudolf A.
Alter, Peter
Watz, Henrik
Vogelmeier, Claus F.
Kauczor, Hans-Ulrich
Thangamani, Subasini
Debic, Manuel
Welte, Tobias
Behr, Jürgen
Kahnert, Kathrin
Bals, Robert
Herr, Christian
Heußel, Claus Peter
Biederer, Jürgen
von Stackelberg, Oyunbileg
Fähndrich, Sebastian
Wouters, Emiel F. M.
Waschki, Benjamin
Rabe, Klaus F.
Herth, Felix J. F.
Palm, Viktoria
Andreas, Stefan
Kanerth, Kathrin
Bahmer, Thomas
Bewig, Burkhard
Ewert, Ralf
Stubbe, Beate
Ficker, Joachim H.
Grohé, Christian
Held, Matthias
Henke, Markus
Kirsten, Anne-Marie
Koczulla, Rembert
Kronsbein, Juliane
Kropf-Sanchen, Cornelia
Herzmann, Christian
Pfeifer, Michael
Randerath, Winfried J.
Seeger, Werner
Studnicka, Michael
Taube, Christian
Timmermann, Hartmut
Schmeck, Bernd
Wirtz, Hubert
,
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 2 July 2024
First Online: 13 July 2024
Declarations
:
: The COSYCONET study was conducted in accordance with the amended Declaration of Helsinki and approved by the Ethics Committees of the coordinating center Marburg and all study centers. Moreover.
: All participants gave their written informed consent.
: FCT reported payments or honoraria for lectures and presentations from Boehringer Ingelheim Chiesi, GlaxoSmithKline, GrifolsNovartis, CSL Behring, Streamed up, RG Gesellschaft für Information and Organisation mbH, PA reports grants from German Federal Ministry of Education and Research (BMBF) Competence Network Asthma and COPD (ASCONET), grants from AstraZeneca GmbH, grants and non-financial support from Bayer Schering Pharma AG, grants, personal fees and non-financial support from Boehringer Ingelheim Pharma GmbH & Co. KG, grants and non-financial support from Chiesi GmbH, grants from GlaxoSmithKline, grants from Grifols Deutschland GmbH, grants from MSD Sharp & Dohme GmbH, grants and personal fees from Mundipharma GmbH, grants, personal fees and non-financial support from Novartis Deutschland GmbH, grants from Pfizer Pharma GmbH, grants from Takeda Pharma Vertrieb GmbH & Co. KG, outside the submitted work. CFV reports grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Chiesi, grants and personal fees from GlaxoSmithKline, grants and personal fees from Grifols, grants and personal fees from Novartis, personal fees from Berlin Chemie/Menarini, personal fees from CSL Behring, grants from German Federal Ministry of Education and Research (BMBF) Competence Network Asthma and COPD (ASCONET), personal fees from Nuvaira, personal fees from MedUpdate, outside the submitted work. HUK reports grants from Siemens, non-financial support from Bayer, during the conduct of the study; grants from Siemens, grants and personal fees from Philips, personal fees from Boehringer Ingelheim, personal fees from Merck Sharp Dohme, personal fees from Astra Zeneca, outside the submitted work. R.B. reports grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, personal fees from GlaxoSmithKline, personal fees from Grifols, grants and personal fees from Novartis, personal fees from CSL Behring, grants from German Federal Ministry of Education and Research (BMBF) Competence Network Asthma and COPD (ASCONET), grants from Sander Stiftung, grants from Schwiete Stiftung, grants from Krebshilfe, grants from Mukoviszidose eV, outside the submitted work. He is Editor in Chief of Respiratory Research. FJF received personal money for adboard activities and lecture fees from Pulmonx, BTG, Olympus and Uptake. RJ, HW, ST, MD, TW, JB, KK, RB, CH, CPC, JB, OvS, SF, EFMW, BW, KFR, VP.
